[HTML][HTML] Long term outcomes of transcatheter aortic valve implantation (TAVI): a systematic review of 5-year survival and beyond

A Chakos, A Wilson-Smith, S Arora… - Annals of …, 2017 - ncbi.nlm.nih.gov
Background Transcatheter aortic valve implantation/replacement (TAVI/TAVR) is becoming
more frequently used to treat aortic stenosis (AS), with increasing push for the procedure in …

Degenerative calcific aortic stenosis: a natural history

B Iung, A Vahanian - Heart, 2012 - heart.bmj.com
Aortic stenosis (AS) is the consequence of active valve remodelling, which can be easily
diagnosed, but for which no preventive strategy is available. It is the most common valve …

Transcatheter aortic-valve replacement for inoperable severe aortic stenosis

RR Makkar, GP Fontana, H Jilaihawi… - … England Journal of …, 2012 - Mass Medical Soc
Background Transcatheter aortic-valve replacement (TAVR) is the recommended therapy for
patients with severe aortic stenosis who are not suitable candidates for surgery. The …

Transcatheter aortic valve replacement in Europe: adoption trends and factors influencing device utilization

D Mylotte, RLJ Osnabrugge, S Windecker… - Journal of the American …, 2013 - jacc.org
Objectives: The authors sought to examine the adoption of transcatheter aortic valve
replacement (TAVR) in Western Europe and investigate factors that may influence the …

Long-term cost-effectiveness of transanal irrigation in patients with neurogenic bowel dysfunction

A Emmanuel, G Kumar, P Christensen, S Mealing… - PloS one, 2016 - journals.plos.org
Background People suffering from neurogenic bowel dysfunction (NBD) and an ineffective
bowel regimen often suffer from fecal incontinence (FI) and related symptoms, which have a …

Improving the methods for the economic evaluation of medical devices

R Tarricone, G Callea, M Ogorevc… - Health …, 2017 - Wiley Online Library
Medical devices (MDs) have distinctive features, such as incremental innovation, dynamic
pricing, the learning curve and organisational impact, that need to be considered when they …

The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk

TA Fairbairn, DM Meads, C Hulme, AN Mather, S Plein… - Heart, 2013 - heart.bmj.com
Objective To determine the cost-effectiveness of transcatheter aortic valve implantation
(TAVI) compared with surgical aortic valve replacement (SAVR) in a high-risk aortic stenosis …

Costs of transcatheter versus surgical aortic valve replacement in intermediate-risk patients

RLJ Osnabrugge, SJ Head, TSS Genders… - The Annals of thoracic …, 2012 - Elsevier
BACKGROUND: Transcatheter aortic valve replacement (TAVR) offers a new treatment
option for patients with aortic stenosis, but costs may play a decisive role in decision making …

A novel geriatric assessment frailty score predicts 2-year mortality after transcatheter aortic valve implantation

E Skaar, LSP Eide, TM Norekvål… - … Journal-Quality of …, 2019 - academic.oup.com
Aims Established surgical scores have limitations in delineating risk among candidates for
transcatheter aortic valve implantation (TAVI). Assessment of frailty might help to estimate …

Future costs, fixed healthcare budgets, and the decision rules of cost‐effectiveness analysis

P van Baal, D Meltzer, W Brouwer - Health economics, 2016 - Wiley Online Library
Life‐saving medical technologies result in additional demand for health care due to
increased life expectancy. However, most economic evaluations do not include all medical …